Is BSX a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

3,279 people get BSX articles and Market Currents by email alert.

Get email alerts on BSX »

FOCUS | PRO | RELATED | TRANSCRIPTS | NEWS & PR

Medtronic And Boston Scientific Are In A Race To Build A Better Pain Device
Peter Geschek • Wed, May 29 • 3 Comments
New Data On Boston Scientific's Atrial Fibrillation Watchman Device Could Lift Outlook
Trefis • Tue, May 14 • 1 Comment
Boston Scientific: A Look At The Cardiac Rhythm Management Division
Trefis • Mon, Mar 25
Is It Finally The Right Time For Boston Scientific?
Stephen Simpson • Wed, Jan 30
Buy Boston Scientific: Down But Not Out
Horizon Investments • Wed, Dec 19, 2012 • 2 Comments
Boston Scientific Could Benefit From St. Jude Medical's Troubles
Trefis • Tue, Nov 27, 2012
Boston Scientific - Another Acquisition Despite Questionable Track Record
The Value Investor • Sun, Nov 11, 2012
Boston Scientific Gatecrashes Renal Denervation Market With Vessix Buy
EP Vantage • Fri, Nov 9, 2012 • 2 Comments
Downside Risks To Boston Scientific's $6 Fair Value
Trefis • Fri, Nov 2, 2012
Boston Scientific's September Earnings Reflect Aggressive Accounting
GMI Ratings • Wed, Oct 24, 2012 • 1 Comment
Boston Scientific: Earnings Decline Coupled With A Weak Market Outlook
Qineqt • Fri, Oct 19, 2012
Boston Scientific Offers More Muddle-Through
Stephen Simpson • Thu, Oct 18, 2012 • 1 Comment
Earnings Review: Boston Scientific Continues To Suffer End Market Weakness
Chandrasekhar Rajagopalan • Thu, Oct 18, 2012
Boston Scientific - Rhythmia Medical, Another $90 Million Acquisition Highlight Poor Acquisition Track Record
The Value Investor • Tue, Oct 9, 2012
FDA Approves Boston Scientific's Defibrillator, But Stock Fairly Priced
Qineqt • Mon, Oct 1, 2012
Boston Scientific's Device To Relieve Severe Asthma: A Major Opportunity
Peter Geschek • Mon, Sep 17, 2012 • 5 Comments
Boston Scientific's President And CEO Agree: It's A Buy
Insider Monkey • Sun, Aug 5, 2012 • 4 Comments
How Can Boston Scientific Still Be This Bad?
Stephen Simpson • Thu, Jul 26, 2012
High Option Volume For Boston Scientific
PowerOptions • Wed, Jun 13, 2012 • 8 Comments
Update: Bullish Case For Boston Scientific
RulingTheMarkets • Thu, May 10, 2012 • 2 Comments

Is It Finally The Right Time For Boston Scientific?
Stephen Simpson • Wed, Jan 30

Gloomy Prospects For Medical Device Companies
Ron Sommer • Sun, Jun 16 • 2 Comments
The 50 Best Performing S&P 500 Stocks in 2013
Bespoke Investment Group • Fri, Jun 7 • 4 Comments
How To Play The Invest-For-Tomorrow Game In Medtech: Alan Brochstein
Life Sciences Report • Thu, Jun 6 • 1 Comment
Johnson & Johnson: Part V - Unacceptable Earnings Growth Decline - Reversal Strategy
Robert Honeywill • Thu, Jun 6
Evaluating Johnson & Johnson's Economic Moat
Daniel Philip • Fri, May 31 • 12 Comments
Johnson & Johnson: At The Crossroads - Part IV - One Road To Higher Profit Growth Rates
Robert Honeywill • Thu, May 23 • 12 Comments
American Society Of Clinical Oncology Abstracts Point To Potential Profits
David Greene • Tue, May 21 • 3 Comments
Cramer's Mad Money - 17 Things To Watch In The Week Ahead (5/17/13)
SA Editor Miriam Metzinger • Mon, May 20
Risky Stocks In An Expensive Market
David Pinsen • Sun, May 19 • 10 Comments
Johnson & Johnson: At The Crossroads - Part III
Robert Honeywill • Thu, May 16
Johnson & Johnson: At The Crossroads - Part II
Robert Honeywill • Fri, May 10 • 1 Comment
Cramer's Mad Money - Reckless Speculative Generals (5/9/13)
SA Editor Miriam Metzinger • Fri, May 10 • 12 Comments
5 Stocks Under $10 To Buy With Solid Fundamentals And Upside
David Alton Clark • Wed, May 8 • 3 Comments
China Biotech In Review: Chindex Buys Israeli Laser Company For $240 Million
ChinaBio Today • Sun, May 5
Stryker: Positioned To Stay Ahead Of The Game, But Will Company Keep Pace?
Emerging Equities • Tue, Apr 23
7 Stocks With Surging Earnings Estimates
StreetAuthority • Mon, Apr 15 • 1 Comment
4 Healthcare Stocks To Get You Well Ahead Of Earnings
Richard Saintvilus • Mon, Apr 15 • 1 Comment
Cramer's Mad Money - 3 Sectors That Have Not Yet Rallied (4/11/13)
SA Editor Miriam Metzinger • Fri, Apr 12
Johnson & Johnson's Equity Doesn't Offer Compelling Margin Of Safety At Current Prices
Tim Travis • Thu, Apr 4 • 1 Comment
Turnaround Opportunities Investors Can Still Capitalize On
D. Mero • Wed, Mar 20 • 3 Comments

Boston Scientific's CEO Presents at 38th Annual Deutsche Bank Health Care Conference (Transcript)
Thu, May 30
Boston Scientific Management Discusses Q1 2013 Results - Earnings Call Transcript
Thu, Apr 25
Boston Scientific's Management Presents at Citi 2013 Global Healthcare Conference (Transcript)
Mon, Feb 25
Boston Scientific Corporation - Analyst/Investor Day
Tue, Feb 12
Boston Scientific Management Discusses Q4 2012 Results - Earnings Call Transcript
Tue, Jan 29
Boston Scientific Management Discusses Q3 2012 Results - Earnings Call Transcript
Thu, Oct 18, 2012
Boston Scientific Management Discusses Q2 2012 Results - Earnings Call Transcript
Thu, Jul 26, 2012
Boston Scientific Corporation - Special Call
Mon, Jun 11, 2012
Boston Scientific's CEO Discusses Q1 2012 Results - Earnings Call Transcript
Thu, Apr 19, 2012 • 1 Comment
Boston Scientific's CEO Discusses Q4 2011 Results - Earnings Call Transcript
Thu, Feb 2, 2012 • 6 Comments
Boston Scientific's CEO Discusses Q3 2011 Results - Earnings Call Transcript
Thu, Oct 20, 2011 • 1 Comment
Boston Scientific's CEO Discusses Q2 2011 Results - Earnings Call Transcript
Thu, Jul 28, 2011
Boston Scientific's CEO Discusses Q1 2011 Results - Earnings Call Transcript
Thu, Apr 21, 2011
Boston Scientific's CEO Discusses Q4 2010 Results - Earnings Call Transcript
Wed, Feb 2, 2011
Boston Scientific Investor Day – Transcript
Sat, Nov 20, 2010 • 1 Comment
Boston Scientific CEO Discusses Q3 2010 Results - Earnings Call Transcript
Wed, Oct 20, 2010
Boston Scientific Corporation Q2 2010 Earnings Conference Call
Wed, Jul 21, 2010 • 1 Comment
Boston Scientific Corporation Q1 2010 Earnings Call Transcript
Tue, Apr 27, 2010
Boston Scientific Corporation Q4 2009 Earnings Call Transcript
Fri, Feb 12, 2010
Boston Scientific Company Q3 2009 Earnings Call Transcript
Tue, Oct 20, 2009

Boston Scientific Vercise™ DBS System demonstrates Improvement In Motor Function For Patients With Parkinson's Disease

PR Newswire (Tue, 12:00AM)
Boston Scientific Begins Patient Enrollment In U.S. Clinical Trial For Use Of Vercise™ DBS System In Treatment Of Parkinson's Disease

PR Newswire (Mon, 5:03PM)
Boston Scientific Announces Collaboration with Pelvic Floor Disorders Network to Study Treatment Strategies for Uterine Prolapse

PR Newswire (Jun 3, 2013)
Boston Scientific Receives CE Mark Approval For GUIDE™ DBS System

PR Newswire (May 27, 2013)
Boston Scientific To Participate In The 38th Annual Deutsche Bank 2013 Healthcare Conference

PR Newswire (May 24, 2013)
New Data Demonstrate Significant And Sustained Blood Pressure Reduction With Boston Scientific Vessix™ Renal Denervation System

PR Newswire (May 22, 2013)
Boston Scientific Reports Lotus™ Valve System Met Primary Performance Endpoint in REPRISE II Trial

PR Newswire (May 22, 2013)
Boston Scientific Promus PREMIER™ And SYNERGY™ Drug-Eluting Stent Systems Provide Exceptional Safety And Efficacy Data

PR Newswire (May 22, 2013)
Boston Scientific Long Term Data Demonstrate Bronchial Thermoplasty Treatment Benefits Persist Out to Five Years in Patients with Severe Asthma

PR Newswire (May 21, 2013)
Jim Cramer's Down and Out Turnaround Play

at CNBC.com (May 17, 2013)
Boston Scientific Presents Clinical Data at Digestive Disease Week®

PR Newswire (May 17, 2013)
Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013

PR Newswire (May 17, 2013)
First Patient Enrolled In Boston Scientific Randomized Study Comparing WallFlex® Biliary RX Stent To Absence Of Biliary Drainage In Patients With Pancreatic Or Periampullary Cancers

PR Newswire (May 15, 2013)
Midday Movers: GILD, BSX, AES & More

at CNBC.com (May 13, 2013)
Data From More Than 100,000 Boston Scientific Implantable Defibrillators Show Battery Longevity Projections Of Nine To 13 Years

PR Newswire (May 10, 2013)
Boston Scientific Receives CE Mark Approval For The Rhythmia™ Mapping System

PR Newswire (May 10, 2013)
Movers & Shakers: Thursday’s movers: Chanos is Seagate’s albatross

at MarketWatch.com (May 9, 2013)
New Four-Year Data From Boston Scientific Demonstrated WATCHMAN® Device Was Superior To Warfarin For Mortality And Primary Efficacy In Patients With Atrial Fibrillation In Long Term Follow-Up Of The PROTECT AF Trial

PR Newswire (May 9, 2013)
Boston Scientific To Participate In The Bank Of America Merrill Lynch 2013 Healthcare Conference

PR Newswire (May 8, 2013)
Boston Scientific Completes First-In-Human Clinical Trial of the IntellaTip MiFi™ XP Ablation Catheter For Patients With Type 1 Atrial Flutter

PR Newswire (May 6, 2013)

BSX vs. ETF Alternatives

Company Description

Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties including cardiac rhythm management, electrophysiology, interventional cardiology, peripheral interventions, neurovascular,... More

Sector: Healthcare

Industry: Medical Instruments & Supplies

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Tuesday, June 18, 8:19 AM Patients with Parkinson's disease showed a 60% mean improvement in motor function after six months in a trial of Boston Scientific's (BSX) Vercise DBS (deep brain stimulation) System. The implant is designed to selectively stimulate targeted areas when inserted in the brain. The study involved 40 subjects. (PR) Comment! [Healthcare]
Monday, June 17, 5:29 PM Boston Scientific (BSX) announces the first implantation of its Vercise DBS System as part of its intrepid clinical trial. The study intends to evaluate the safety and effectiveness of motor function and overall quality of life in patients using the Vercise DBS System for the treatment of Parkinson's disease. Shares -0.3% AH. Comment! [Healthcare]
Friday, May 31, 10:53 AM Wedbush initiates several medical equipment and supply names. Rundown: Boston Scientific (BSX +0.8%), which is "progressing with its turnaround story," is started at Neutral (price target $10) with new product intros serving as "catalysts for higher EPS"; Medtronic (MDT) is started at Neutral (price target $52) and is "an 800-lb. gorilla [facing] growing competition, limited near-term growth, and an overextended valuation"; St. Jude Medical (STJ -0.9%) is started at Outperform (price target $57) as the Durata overhang "is beginning to lose some steam enabling investors to refocus on STJ's healthy pipeline." 1 Comment [Healthcare]
Wednesday, May 22, 2:14 PM Boston Scientific (BSX -1%) slides in spite of reporting positive results earlier today from a pre-specified analysis of the first 60 patients enrolled in its trial evaluating the performance and safety of the Lotus Valve System in symptomatic patients with severe aortic valve disease considered at high risk for surgical valve replacement. The results showed the trials met primary endpoints in both performance and safety. Comment! [Healthcare]
Tuesday, May 21, 11:54 AM Boston Scientific (BSX +0.4%) says five-year data from its Asthma Intervention Research 2 clinical trial presented today demonstrated that the Alair Bronchial Thermoplasty System continues to show benefits in adult patients with severe uncontrolled asthma. The system was shown to provide a sustained reduction in the rate of severe asthma attacks and ER visits over a five year period after treatment. Results were presented at the annual meeting of the American Thoracic Society in Philadelphia Comment! [Healthcare]
Wednesday, May 15, 3:44 PM Boston Scientific (BSX +4.4%) is set to finish strong today after announcing earlier that it's first patient has been enrolled in a clinical investigation evaluating the use of its WallFlex Biliary RX Stent, a self-expanding metal stent used as a bridge to surgery. The study is expected to enroll 294 patients at leading hospitals in Australia, Belgium, Canada, France, Hong Kong, India, Italy and Japan. Comment! [Healthcare, On the Move]
Friday, May 10, 4:33 PM Medtronic (MDT) says data presented at the Heart Rhythm Society's 34th Annual Scientific Sessions show its Lead Integrity Alert software detected pace/sense lead issues in non-MDT leads at a greater rate than standard impedance monitoring alone. The analysis, which focused on BSX's Endotak leads, shows that for every one Endotak pace/sense lead issue detected by impedance monitoring, the LIA software detected four cases that were missed. Comment! [Healthcare]
Thursday, May 9, 2:12 PM Boston Scientific (BSX +5%) hits a new 52-week high after reporting follow-up data from its Protect AF clinical trial demonstrating that its Watchman Left Atrial Appendage Closure device was statistically superior to Bristol-Myers (BMY) Warfarin in preventing cardiovascular death, strokes and systemic embolization. 1 Comment [Healthcare, On the Move]
Friday, April 26, 2:48 PM Boston Scientific (BSX -1.6%) gives back a pre-market pop plus more today, despite being upped to Outperform at Credit Suisse with a price target of $8.75. The firm says the company is on track for the first time in years to post positive sales growth, and that management's "continued commitment to returning to positive sales growth H213 & to improving margins despite a tough pricing environment" is encouraging. Comment! [Healthcare, On the Move]
Thursday, April 25, 10:05 AM More on Boston Scientific (BSX +1.2%) Q1: swings to net loss of $354M from a profit of $113M a year earlier after taking charges of $578M for litigation and restructuring expenses. Sales breakdown: cardiovascular +12%, rhythm management -5%, MedSurg sales +2%. Expects Q2 adjusted EPS of $0.14-0.17 vs consensus of $0.10, and revenue of $1.74-1.8B vs $1.81B; Revises FY guidance: now expects EPS of $0.65-0.70 vs prior outlook of $0.64-0.70 and consensus of $0.41; and revenues of $6.95-7.15B vs $7.05-7.35B prior and expectations of $7.18B. (PR) Comment! [Healthcare, Earnings]
Thursday, April 25, 7:04 AM Boston Scientific (BSX): Q1 EPS of $0.16 beats by $0.07. Revenue of $1.76B (-6% Y/Y) misses by $0.03B. (PR) Comment! [Earnings, Breaking News, Healthcare]
Thursday, April 25, 12:05 AM Notable earnings before Thursday’s open: ABC, AIXG, ALK, ALXN, AME, ASPS, AVT, AZN, BC, BG, BIIB, BLL, BMS, BMY, BSX, BWA, CAB, CAM, CCE, CELG, CFX, CL, CMS, CNX, COP, CRR, CSH, D, DAN, DLX, DNKN, DO, DOW, DST, EQT, ESI, ETR, FAF, GPK, GTI, GTLS, HERO, HOG, HP, HSY, IDCC, IMAX, JBLU, KKR, KMT, LEA, LINE, LKQ, LLL, LUV, LVLT, MDP, MJN, MMM, MO, NBL, NLSN, NMM, NYT, O, ODFL, ORI, OXY, PCS, PDS, PH, PHM, POT, PRLB, PTEN, PVR, RCL, RDWR, RRD, RS, RTN, RYN, SCG, SIAL, SUI, SWK, SWY, TASR, TSRA, TWC, UAL, UPS, UTHR, WBC, XOM, YNDX, ZMH Comment! [Earnings]
Wednesday, April 24, 5:30 PM Notable earnings before Thursday’s open: ABC, AIXG, ALK, ALXN, AME, ASPS, AVT, AZN, BC, BG, BIIB, BLL, BMS, BMY, BSX, BWA, CAB, CAM, CCE, CELG, CFX, CL, CMS, CNX, COP, CRR, CSH, D, DAN, DLX, DNKN, DO, DOW, DST, EQT, ESI, ETR, FAF, GPK, GTI, GTLS, HERO, HOG, HP, HSY, IDCC, IMAX, JBLU, KKR, KMT, LEA, LINE, LKQ, LLL, LUV, LVLT, MDP, MJN, MMM, MO, NBL, NLSN, NMM, NYT, O, ODFL, ORI, OXY, PCS, PDS, PH, PHM, POT, PRLB, PTEN, PVR, RCL, RDWR, RRD, RS, RTN, RYN, SCG, SIAL, SUI, SWK, SWY, TASR, TSRA, TWC, UAL, UPS, UTHR, WBC, XOM, YNDX, ZMH Comment! [Earnings]
Friday, April 12, 3:48 PM Boston Scientific (BSX +0.4%) says it's received FDA approval for its Precision Spectra Spinal Cord Stimulator System. The system, which will be launch on a limited basis in the U.S., uses Illumina 3D software and 32 contacts and is designed to provide improved pain relief to patients who suffer from chronic pain. Comment! [Healthcare]
Thursday, April 11, 4:16 PM Shares of Boston Scientific (BSX -1.5%) tanked into the close of trading today, with no significant news hitting the tape. Comment! [Healthcare, On the Move]
Wednesday, April 3, 2:45 PM Boston Scientific (BSX -2.2%) dips after Credit Suisse analyst Bruce Nudell cut the shares from Outperform to Neutral on valuation earlier today. In his report, Nudell notes that while he doesn't see its current valuation as overstretched, the shares are now within 8% of his target price and with elevated expectations from the Street already priced in, the stock no longer has enough upside to warrant the higher rating. Comment! [Healthcare, On the Move]

Ryan Mallory
Lazy Trade Long & Short: $BSX & $SPWR | SharePlanner http://bit.ly/Znlza5
Apr 10, 3:31 PM
Reply (2)

• !Report Abuse
View all 2 replies
rongsc: man, should've seen $SPWR as a short play... doh, got carried away with $FSLR's high. a little now. :(
Apr 10, 9:59 PM
• !Report Abuse
Ryan Mallory: don't worry - i missed the breakout on DISCK today... was a beauty
Apr 11, 8:29 AM
• !Report Abuse
Add a reply...

140 characters

Daniel Lauchheimer
Could b M Zuckerman resigns from $BSX to launch campaign 4 mayor of nyc. has rejected interest b/c of desire to spend time w fam. Suspicius
Mar 13, 3:53 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Michael Bryant
Boston Scientific's ($BSX) stock is down a lot. Shares could easily hit $11. http://yhoo.it/VwSMEE;c=
Jan 31, 12:44 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Michael Bryant
Boston Scientific ($BSX) "topped analyst expectations with its fourth-quarter earnings report." Time to buy. http://yhoo.it/11jbn3T
Jan 31, 12:41 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

VFC's Stock House
Stock Watch Tuesday, 11 Dec - $CLDX, $MRIC.OB, $INO, $BSX, $SI, $DNDN, $MDVN, $MCD, $YUM http://bit.ly/cAHZ42
12/11/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Lukethegook
BSX In at 5.05, good so far
8/12/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Roxieanne
BSX, SIRI, Fi
4/30/12
Reply (2)

• !Report Abuse
View all 2 replies
Roxieanne: BSX, SIRI, F
4/30/12
• !Report Abuse
Roxieanne: What is this? Doesn't make sense
5/29/12
• !Report Abuse
Add a reply...

140 characters

1980XLS-2.0
BSX very strong as of late.
4/27/12
Reply (3)

• !Report Abuse
View all 3 replies
1980XLS-2.0: Stock is worth holding over the summer on Tropical storm speculation.
4/27/12
• !Report Abuse
1980XLS-2.0: Had 10K shrs summer 2005. Made $65K off of Hurricane Katrina. "FEMA Rich"
4/27/12
• !Report Abuse
Add a reply...

140 characters

SobaNoodle
BSX, nice reaction after earnings. Let's see if it can follow through for the rest of the day. Long May 5 calls.
4/19/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

lfpdinc
BSX & CLWR did not get the memo
4/17/12
Reply (3)

• !Report Abuse
View all 3 replies
Funkengruven: Give it time... oil, water, & spectrum... need em!
4/17/12
• !Report Abuse
DAG1996: you forgot nat-gas, not to mention food and shelter... and Skittles, of course
4/17/12
• !Report Abuse
Add a reply...

140 characters

LATEST REPLIES

Ryan Mallory
Lazy Trade Long & Short: $BSX & $SPWR | SharePlanner http://bit.ly/Znlza5
Apr 10, 3:31 PM
Reply (2)

• !Report Abuse
View all 2 replies
rongsc: man, should've seen $SPWR as a short play... doh, got carried away with $FSLR's high. a little now. :(
Apr 10, 9:59 PM
• !Report Abuse
Ryan Mallory: don't worry - i missed the breakout on DISCK today... was a beauty
Apr 11, 8:29 AM
• !Report Abuse
Add a reply...

140 characters

Roxieanne
BSX, SIRI, Fi
4/30/12
Reply (2)

• !Report Abuse
View all 2 replies
Roxieanne: BSX, SIRI, F
4/30/12
• !Report Abuse
Roxieanne: What is this? Doesn't make sense
5/29/12
• !Report Abuse
Add a reply...

140 characters

1980XLS-2.0
BSX very strong as of late.
4/27/12
Reply (3)

• !Report Abuse
View all 3 replies
1980XLS-2.0: Stock is worth holding over the summer on Tropical storm speculation.
4/27/12
• !Report Abuse
1980XLS-2.0: Had 10K shrs summer 2005. Made $65K off of Hurricane Katrina. "FEMA Rich"
4/27/12
• !Report Abuse
Add a reply...

140 characters

lfpdinc
BSX & CLWR did not get the memo
4/17/12
Reply (3)

• !Report Abuse
View all 3 replies
Funkengruven: Give it time... oil, water, & spectrum... need em!
4/17/12
• !Report Abuse
DAG1996: you forgot nat-gas, not to mention food and shelter... and Skittles, of course
4/17/12
• !Report Abuse
Add a reply...

140 characters

1980XLS-2.0
BSX on a tear today. Too busy and missed that one.
3/8/12
Reply (1)

• !Report Abuse
View all 1 replies
SobaNoodle: that thing has been manic depressive now for two weeks. Still holding some May calls.
3/8/12
• !Report Abuse
Add a reply...

140 characters

SobaNoodle
AFL & COP longs still working. BSX, not so much.
3/1/12
Reply (2)

• !Report Abuse
View all 2 replies
John Rayhall: I sold my shares at 6.28 wish I had sold my May calls the other day but there is still time
3/1/12
• !Report Abuse
John Rayhall: So they bid it up to 6.40 only to sell it off to 6? Interesting
3/2/12
• !Report Abuse
Add a reply...

140 characters

John Rayhall
BSX up 6% the May $7 calls up nicely as well. looks like it's poised for a nice run.
2/24/12
Reply (2)

• !Report Abuse
View all 2 replies
fastjetm: yep, loaded up, also NOK have a look, Mr. Softy's smart Windows phone ;)
2/24/12
• !Report Abuse
John Rayhall: Ya NOK had a nice day I've traded it before it may be recovering slowly. Thanks :)
2/24/12
• !Report Abuse
Add a reply...

140 characters

1980XLS-2.0
BSX, rallying AH.
2/22/12
Reply (15)

• !Report Abuse
View all 15 replies
1980XLS-2.0: check option activity if you are in the game. That's what got me in @ $5.29 that time.
2/24/12
• !Report Abuse
John Rayhall: Think there was heavy trading in the March $6 options recently
2/24/12
• !Report Abuse
Add a reply...

140 characters

SobaNoodle
LOL at the option action in BSX. Many dates, but seriously weird trades with volume of 1 in all sorts of strikes.
2/24/12
Reply (2)

• !Report Abuse
View all 2 replies
SobaNoodle: a May $1 call for $6.30?!? The stock is cheaper than that.
2/24/12
• !Report Abuse
John Rayhall: Stock going nuts today. I don't think anyone would but them out JNJ rumored for years but you neevr know I guess I own the May 7 calls
2/24/12
• !Report Abuse
Add a reply...

140 characters

John Rayhall
What do you think guys get back into some BSX?
2/21/12
Reply (2)

• !Report Abuse
View all 2 replies
SobaNoodle: I like it w/ ST target @6.80 or so. I'd probably take a shot with 5 strike calls, since there's so little time premium in them.
2/21/12
• !Report Abuse
John Rayhall: I own some May $7 calls which have been doing decent lately those are more of a gamble. I will take a look at the 5 strike calls thanks :)
2/21/12
• !Report Abuse
Add a reply...

140 characters

1980XLS-2.0
BSX, so much for that earnings dip!
2/3/12
Reply (8)

• !Report Abuse
View all 8 replies
1980XLS-2.0: That sounds about right. Not bad for a few months out, (a fairly low risk options play)
2/3/12
• !Report Abuse
John Rayhall: Got them fairly cheap if the market stays strong BSX should get to 7 easy.
2/3/12
• !Report Abuse
Add a reply...

140 characters

John Rayhall
BTFD worked again on KWK like it did on REXX and RVBD nice! Sold the rest of my BSX at 5.80 should have yesterday oh well bought BYD
2/2/12
Reply (10)

• !Report Abuse
View all 10 replies
John Rayhall: That stock has no place in momo trading.
2/2/12
• !Report Abuse
John Rayhall: It's about as micro cap as they come pretty risky
2/2/12
• !Report Abuse
Add a reply...

140 characters

1980XLS-2.0
HaHa, Got rid of the last of my BSX yesterday. THAT's why I don't do earnings
2/2/12
Reply (3)

• !Report Abuse
View all 3 replies
jason2788: can i grow up to be like you....seriously....no homo.
2/2/12
• !Report Abuse
1980XLS-2.0: don't know, as did not analize data nor listen to CC, as I have no vested interest.
2/2/12
• !Report Abuse
Add a reply...

140 characters

SobaNoodle
Anybody else still on the BSX train and holding through earnings? Took profits in 1/2 position today after a nice up move.
2/1/12
Reply (3)

• !Report Abuse
View all 3 replies
1980XLS-2.0: EW had huge day yesterday, likely responsible for some of the move.
2/1/12
• !Report Abuse
John Rayhall: I sold half of my position but holding the other half let it ride! Lol Own some May calls as well let's see what happens.
2/1/12
• !Report Abuse
Add a reply...

140 characters

1980XLS-2.0
BSX on the move again
1/25/12
Reply (6)

• !Report Abuse
View all 6 replies
John Rayhall: Thanks Brian :)
1/25/12
• !Report Abuse
John Rayhall: Hmmm BSX down to 6 guess it's still in consolidation mode I may sell some though
1/26/12
• !Report Abuse
Add a reply...

140 characters

BSX Boston Scientific Corporation

BSX

Boston Scientific Corporation